The last remaining antibiotics used to treat gonorrhoea (cefixime and ceftriaxone) in England and Wales are becoming less effective. But recent changes in prescribing practice, based on new recommendations that challenge previous public health thinking, seem to have delayed or reversed this trend, and may help to delay the growing threat of multi-drug resistant gonorrhoea, suggests new research published Online First in The Lancet Infectious Diseases. "Fears continue that the current cephalosporins will become ineffective...
More...
More...